Signs of neurodegeneration in individuals with Down syndrome may start as early as birth, a critical stage of brain ...

Women with Down syndrome have more advanced signs of Alzheimer's disease than men do at the average age of diagnosis, which is the same for both sexes, according to research by the University of ...

Adults with both Down syndrome and congenital heart defects, also known as congenital heart disease (CHD), are showing remarkable resilience despite facing significant medical challenges, according to ...

By Nancy Lapid April 17 (Reuters) - Researchers have developed a modified version of the CRISPR gene-editing tool that in ...

Researchers conducted a nationwide registry-based cohort study to compare the cumulative incidence of AKI and CKD across the lifespan in 2815 patients with Down syndrome with that in 28,150 age- and ...

Researchers have dosed the first participant in a clinical trial of an investigational medicine designed to lower the amount of amyloid precursor protein (APP) for the potential treatment of Alzheimer ...

Deaf children can now hear thanks to a new treatment that repairs a defective gene. Researchers associated with the biotech ...

Every few weeks, Evan Dewey comes from his home in Atlanta up to the Vanderbilt Center for Cognitive Medicine. He's in an ABATE clinical trial. The hope is to reduce the risk of Alzheimer's in people ...

Down syndrome is a genetic disorder caused by an extra copy of chromosome 21. Along with causing intellectual disability and physical health issues, this condition may make a person more prone to ...

A groundbreaking new study reports important differences in oxygen physiology and red blood cell function in individuals with Down syndrome. A groundbreaking new study published in Cell Reports by ...

Researchers from Case Western Reserve University School of Medicine have developed a breakthrough, noninvasive technique to develop stem cells strongly relevant to the study of Down syndrome. Writing ...

Pediatric patients with Down syndrome have a greater prevalence of overall and specific nail disorders than control patients.